NEWLY approved for marketing in Australia, Praluent (alirocumab), a monoclonal antibody, is second in a new class of medicines indicated for a small group of patients with high cholesterol who are difficult to treat and have high cardiac risk.
PBAC will consider listing in Mar.
THE Remote and Isolated Pharmacist Association Australia (RIPAA) has welcomed the WA Government’s initiative to subsidise the cost of training for expanded scope of practice, in particular the higher subsidy offered to rural pharmacists in MM3-7 (PD 22 Jul).
INSTITUTIONS and experts are no longer the sole gatekeepers of health information, and peers, influencers and social platforms now play a central role in shaping health behaviours, according to new data launched this week from the 2025 Edelman Trust Barometer Special Report: Trust and Health in Australia.
ADVANCED Pharmacy Australia (AdPha) has released a newly updated pharmacy practice standard for general medicine.
Notifications
